Danny In The Valley

Apeiron’s Christian Angermayer: “AI, psychedelics and living for hundreds of years”

12.08.2023 - By The Sunday TimesPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

The Sunday Times' tech correspondent Danny Fortson brings on Christian Angermayer, founder of Apeiron Investments, to talk about psychedelics in Oregon (4:15), the spiritual experience of a “trip” (11:30), progressing toward the first FDA approval (15:30), how this will be introduced into the market (21:10), why having a qualified guide/therapist is critical (25:30), gaining societal acceptance (30:20), why he funded the longevity XPrize (34:20), the new approach to ageing (41:00), why we are on the cusp of a breakthrough in life span (42:30), the Ozempic effect (49:00, thriving in a toxic society (56:20), and how AI dovetails with psychedelics and longevity (1:01:50). Hosted on Acast. See acast.com/privacy for more information.

More episodes from Danny In The Valley